Logs: Bennett Institute
The following is a list of all job requests run via OpenSAFELY by Bennett Institute users.
| Status | Project | Workspace | Request ID | Backend | Jobs | User | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Failed | COVID-19 Vaccine Effectiveness | vax-fourth-dose-rd-baseline | 16688 | TPP | 0/2 | Andrea Schaffer | - | View, Job request 16688 |
| Failed | COVID-19 Vaccine Effectiveness | vax-fourth-dose-rd-baseline | 16687 | TPP | 0/1 | Andrea Schaffer | 2 years, 11 months ago 24 March 2023 21:47:38 UTC | View, Job request 16687 |
| Failed | Scarlet fever and invasive group A strep cases during the COVID-19 pandemic | strepa_scarlet | 16682 | TPP | 4/7 | Christine Cunningham | 2 years, 11 months ago 24 March 2023 14:57:17 UTC | View, Job request 16682 |
| Failed | COVID-19 Vaccine Effectiveness | vax-fourth-dose-rd-baseline | 16678 | TPP | 0/2 | Andrea Schaffer | 2 years, 11 months ago 24 March 2023 16:17:31 UTC | View, Job request 16678 |
| Failed | COVID-19 Vaccine Effectiveness | vax-fourth-dose-rd-baseline | 16677 | TPP | 0/1 | Andrea Schaffer | 2 years, 11 months ago 24 March 2023 09:49:51 UTC | View, Job request 16677 |
| Failed | COVID-19 Vaccine Effectiveness | vax-fourth-dose-rd-baseline | 16676 | TPP | 0/1 | Andrea Schaffer | 2 years, 11 months ago 24 March 2023 09:48:08 UTC | View, Job request 16676 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16669 | TPP | 2/2 | Bang Zheng | 2 years, 11 months ago 23 March 2023 22:39:57 UTC | View, Job request 16669 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16667 | TPP | 1/1 | Bang Zheng | 2 years, 11 months ago 23 March 2023 17:00:30 UTC | View, Job request 16667 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16660 | TPP | 1/1 | Bang Zheng | 2 years, 11 months ago 23 March 2023 16:32:05 UTC | View, Job request 16660 |
| Failed | COVID-19 Vaccine Effectiveness | vax-fourth-dose-rd-baseline | 16659 | TPP | 4/6 | Andrea Schaffer | 2 years, 11 months ago 23 March 2023 15:48:45 UTC | View, Job request 16659 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16658 | TPP | 4/4 | Linda Nab | 2 years, 11 months ago 23 March 2023 14:23:20 UTC | View, Job request 16658 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16657 | TPP | 0/1 | Bang Zheng | 2 years, 11 months ago 23 March 2023 13:43:15 UTC | View, Job request 16657 |
| Succeeded | COVID-19 Vaccine Effectiveness | vax-fourth-dose-rd-baseline | 16642 | TPP | 1/1 | Andrea Schaffer | 2 years, 11 months ago 23 March 2023 10:16:16 UTC | View, Job request 16642 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16640 | TPP | 0/1 | Bang Zheng | 2 years, 11 months ago 23 March 2023 11:24:48 UTC | View, Job request 16640 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16637 | TPP | 0/1 | Bang Zheng | 2 years, 11 months ago 23 March 2023 09:47:44 UTC | View, Job request 16637 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16630 | TPP | 0/1 | Bang Zheng | 2 years, 11 months ago 23 March 2023 07:14:37 UTC | View, Job request 16630 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16629 | TPP | 0/1 | Bang Zheng | - | View, Job request 16629 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16628 | TPP | 0/1 | Bang Zheng | 2 years, 11 months ago 22 March 2023 23:27:59 UTC | View, Job request 16628 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16627 | TPP | 0/1 | Bang Zheng | 2 years, 11 months ago 22 March 2023 22:35:06 UTC | View, Job request 16627 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16624 | TPP | 0/1 | Bang Zheng | 2 years, 11 months ago 22 March 2023 20:56:58 UTC | View, Job request 16624 |
| Succeeded | COVID-19 Vaccine Effectiveness | vax-fourth-dose-rd-baseline | 16605 | TPP | 4/4 | Andrea Schaffer | 2 years, 11 months ago 22 March 2023 15:31:04 UTC | View, Job request 16605 |
| Failed | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16602 | TPP | 0/3 | Linda Nab | 2 years, 11 months ago 22 March 2023 15:07:29 UTC | View, Job request 16602 |
| Failed | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16600 | TPP | 0/4 | Linda Nab | 2 years, 11 months ago 22 March 2023 14:59:45 UTC | View, Job request 16600 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16586 | TPP | 1/1 | Bang Zheng | 2 years, 11 months ago 21 March 2023 22:45:36 UTC | View, Job request 16586 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16585 | TPP | 0/1 | Bang Zheng | 2 years, 11 months ago 21 March 2023 21:35:52 UTC | View, Job request 16585 |